L-arginine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Aminosyn II 7 %, Sulfite-free, Clinimix 2.75/5, Clinimix E 2.75/5, Olimel
Generic Name
L-arginine
DrugBank Accession Number
DB17289
Background

Not Available

Type
Small Molecule
Groups
Approved, Nutraceutical
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
L-arginine hydrochlorideNot Available32042-43-6Not applicable
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
AminosynL-arginine (980 mg / 100 mL) + Alanine (1280 mg / 100 mL) + Glycine (1280 mg / 100 mL) + Histidine (300 mg / 100 mL) + Isoleucine (720 mg / 100 mL) + Leucine (940 mg / 100 mL) + Lysine acetate (720 mg / 100 mL) + Methionine (400 mg / 100 mL) + Phenylalanine (440 mg / 100 mL) + Proline (860 mg / 100 mL) + Serine (420 mg / 100 mL) + Threonine (520 mg / 100 mL) + Tryptophan (160 mg / 100 mL) + Tyrosine (44 mg / 100 mL) + Valine (800 mg / 100 mL)SolutionIntravenousIcu Medical Canada Inc1979-12-312019-01-24Canada flag
Aminosyn IIL-arginine (1018 mg / 100 mL) + Alanine (993 mg / 100 mL) + Aspartic acid (700 mg / 100 mL) + Glutamic acid (738 mg / 100 mL) + Glycine (500 mg / 100 mL) + Histidine (300 mg / 100 mL) + Isoleucine (660 mg / 100 mL) + Leucine (1000 mg / 100 mL) + Lysine acetate (1050 mg / 100 mL) + Methionine (172 mg / 100 mL) + N-acetyltyrosine (270 mg / 100 mL) + Phenylalanine (298 mg / 100 mL) + Proline (722 mg / 100 mL) + Serine (530 mg / 100 mL) + Threonine (400 mg / 100 mL) + Tryptophan (200 mg / 100 mL) + Valine (500 mg / 100 mL)SolutionIntravenousIcu Medical Canada Inc1987-12-31Not applicableCanada flag
Aminosyn IIL-arginine (1527 mg / 100 mL) + Alanine (1490 mg / 100 mL) + Aspartic acid (1050 mg / 100 mL) + Glutamic acid (1107 mg / 100 mL) + Glycine (750 mg / 100 mL) + Histidine (450 mg / 100 mL) + Isoleucine (990 mg / 100 mL) + Leucine (1500 mg / 100 mL) + Lysine acetate (1575 mg / 100 mL) + Methionine (258 mg / 100 mL) + N-acetyltyrosine (405 mg / 100 mL) + Phenylalanine (447 mg / 100 mL) + Proline (1083 mg / 100 mL) + Serine (795 mg / 100 mL) + Threonine (600 mg / 100 mL) + Tryptophan (300 mg / 100 mL) + Valine (750 mg / 100 mL)SolutionIntravenousIcu Medical Canada Inc1995-12-31Not applicableCanada flag
AMINOVEN SOLUTION FOR INFUSION 15%L-arginine (20 g/L) + Alanine (25 g/L) + Glycine (18.5 g/L) + Histidine (7.3 g/L) + Isoleucine (5.2 g/L) + Leucine (8.9 g/L) + Lysine acetate (11.1 g/L) + Methionine (3.8 g/L) + Phenylalanine (5.5 g/L) + Proline (17 g/L) + Serine (9.6 g/L) + Taurine (2 g/L) + Threonine (8.6 g/L) + Tryptophan (1.6 g/L) + Tyrosine (0.4 g/L) + Valine (5.5 g/L)SolutionIntravenousFRESENIUS KABI (SINGAPORE) PTE LTD2021-09-30Not applicableSingapore flag
ClinimixL-arginine (690 mg / 100 mL) + Alanine (1242 mg / 100 mL) + Dextrose, unspecified form (5 g / 100 mL) + Glycine (618 mg / 100 mL) + Histidine (288 mg / 100 mL) + Isoleucine (360 mg / 100 mL) + Leucine (438 mg / 100 mL) + Lysine hydrochloride (348 mg / 100 mL) + Methionine (240 mg / 100 mL) + Phenylalanine (336 mg / 100 mL) + Proline (408 mg / 100 mL) + Serine (300 mg / 100 mL) + Threonine (252 mg / 100 mL) + Tryptophan (108 mg / 100 mL) + Tyrosine (24 mg / 100 mL) + Valine (348 mg / 100 mL)SolutionIntravenousBaxter LaboratoriesNot applicableNot applicableCanada flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
74-79-3
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
Not Available
Wikipedia
Arginine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2Active Not RecruitingTreatmentCarcinoid Tumors / Medulloblastomas / Neuroblastoma (NB) / Neuroendocrine Tumors1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionIntravenous18.5 g/L
SolutionIntravenous
SolutionIntravenous25 g/L
EmulsionIntravenous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at December 01, 2022 22:27 / Updated at December 13, 2022 10:46